Señales en vivo de STIM | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally...

Stats
Volumen de hoy	41 757.00
Volumen promedio	162 132
Capitalización de mercado	113.37M
EPS	$0 ( 2024-03-05 )
Próxima fecha de ganancias	( $-0.330 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.63
ATR14	$0.0220 (0.58%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-29	Macan William Andrew	Buy	15 000	Common Stock
2024-02-28	Macan William Andrew	Sell	22 377	Common Stock
2024-02-29	Macan William Andrew	Sell	6 026	Common Stock
2024-02-29	Furlong Stephen	Buy	15 000	Common Stock
2024-02-27	Furlong Stephen	Sell	21 272	Common Stock

INSIDER POWER
17.45
Last 100 transactions
Buy: 1 892 506 \| Sell: 1 430 741

Volumen Correlación

Largo: 0.03 (neutral)

Corto: -0.58 (weak negative)

Signal:(51.954) Neutral

Neuronetics Inc Correlación

10 Correlaciones Más Positivas
AMRB	0.956
COLL	0.928
MDRX	0.913
NETE	0.908
FGFPP	0.908
MMAC	0.907
LWAC	0.901
ERIE	0.899
SPRO	0.891
NGCA	0.89

10 Correlaciones Más Negativas
SVAC	-0.929
PAYO	-0.904
TLGT	-0.902
PRVA	-0.886
PAIC	-0.885
RMRM	-0.883
MRUS	-0.88
WAVD	-0.875
TCFC	-0.873
MTSL	-0.868

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neuronetics Inc Correlación - Moneda/Commodity

0.20
( neutral )

0.65
( weak )

0.00
( neutral )

-0.03
( neutral )

0.45
( neutral )

-0.72
( moderate negative )

Neuronetics Inc Finanzas

Annual	2023
Ingresos:	$71.35M
Beneficio Bruto:	$49.70M (69.66 %)
EPS:	$-1.050

FY	2023
Ingresos:	$71.35M
Beneficio Bruto:	$49.70M (69.66 %)
EPS:	$-1.050

FY	2022
Ingresos:	$65.21M
Beneficio Bruto:	$49.72M (76.26 %)
EPS:	$-1.460

FY	2021
Ingresos:	$55.31M
Beneficio Bruto:	$43.66M (78.93 %)
EPS:	$-1.186

Financial Reports:

No articles found.

Neuronetics Inc

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Actualizaciones en tiempo real para Neuronetics Inc [STIM]

Upcoming Earnings Alert